The New York Entrepreneur

GSK shares jump on win in Delaware court over ongoing Zantac battle

Read Time:9 Second

Delaware’s top court ruled in GSK’s favor in saying it will review the admissibility of expert evidence in an upcoming trial over possible cancer risks from its Zantac heartburn remedy

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post Here’s how Nvidia can keep crushing its AI rivals and the stock market  
Next post Ryanair boss calls for two-drink limit at airports as inflight violence rises